Analysts think DSM is fairly priced

DSM 's stock price seems, partly because of the recent share price rises, to be in line with most of the estimates. Most of the analysts say DSM is fairly priced now. Currently the company is being followed by 21 analysts. The average target price for the stock is at 81,79 euros. This is around 0,28 percent more than the current stock price of 80,8 euros.

Much doubt valuations DSM

Over the current book year the total revenue will be 8,53 billion euros (consensus estimates). This is slightly more than 2016's revenue of 7,92 billion euros.

Historical revenues and results DSM plus estimates 2018

The analysts expect for 2018 a net profit of 662 million euros. For this year most of the analysts expect a profit per share of 3,85 euros. With this the price/earnings-ratio is 20,99.

Per share the analysts expect a dividend of 1,86 euros per share. Thus the dividend yield equals 2,3 percent. The average dividend yield of the chemical companies equals a moderate 1 percent.

Recent target prices around 94 euros

The latest 3 recommendations for the chemical company were provided by KBC Securities, ING and ABN AMRO.

DSM 's market capitalization is based on the number of outstanding shares around 14,13 billion euros.

Historical stock prices DSM

At 13.04 the stock trades 0,59 percent lower at 80,8 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.